Detalhe da pesquisa
1.
Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sézary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study.
Br J Dermatol
; 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38596857